Vaccines

For children who have either experienced a delay in pertussis vaccination or who haven’t received the recommended number of doses, what is their risk of pertussis? A new study provides answers.

Patient portals can be a powerful communication tool for both clinician and family, but can they also be used to improve uptake of the annual influenza vaccine?

Hospitalized children are often at risk of influenza morbidity and mortality, which means that influenza vaccination before discharge can help mitigate those risks. A study discusses how a quality improvement program could make a difference.

Rotavirus can lead to gastrointestinal concerns that can be hazardous to children when rehydration isn’t readily available, which means that a safe, effective vaccine could be life-saving. A meta-analysis examines the safety and efficacy of available immunizations.

Parents and children are eager to get back to “normal” as the number of COVID-19 cases drops, so targeted education and individualized advice are important for families in an almost post–COVID-19 world. Pediatricians can provide guidance about what is and isn’t safe.

Contemporary Pediatrics speaks with Dr. Jeffrey Gerber about when we will see COVID-19 vaccines for children aged less than 12 years.

There are many reasons why a caregiver may refuse to have his or her child receive the human papillomavirus (HPV) vaccine, including safety concerns. A research letter examines whether those concerns have increased.

Many pregnant women are given the season influenza vaccination to provide protection for both mother and child. A study examines whether this vaccination is linked to adverse health outcomes in childhood.

The last meeting of the COVID-19 vaccine congress from the International Society for Vaccines (ISV) provided information on the hypersensitivity events tied to mRNA vaccines as well as the most recent information on the Janssen and Novavax vaccines.

The human papillomavirus (HPV) vaccine is a key intervention for a number of cancers, but the opportunity to discuss the vaccine is missed all too often. Could an online educational program help clinicians improve their HPV vaccine communication strategies?

The company has publicized data from the TeenCOVE study of the vaccine along with plans to seek authorization in the coming weeks.

A recently updated Practice Advisory from the American College of Obstetricians and Gynecologists (ACOG) provides an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.

Eligible children and teens should receive COVID-19 vaccination to protect them from COVID-19 infection, as well as to reduce the spread of the virus in the community and to vulnerable people, according to the statement from the North American Society for Pediatric and Adolescent Gynecology (NASPAG) .

Contemporary Pediatrics sat down with Dr. Donna Hallas to discuss how to communicate with parents as well as how to address vaccines missed because of the pandemic.

The American Academy of Pediatrics (AAP) issued a statement that urges parents get all children and teenagers aged 12 and older vaccinated with Pfizer/BioNTech vaccine, which recently had its authorization expanded.

The US Food and Drug Administration expanded the emergency use authorization of the 2-dose vaccine to include children aged 12 to 15 years.

The International Society for Vaccines (ISV) presented its fifth update on COVID-19 vaccines around the world. This update focused on vaccines produced in China.

It’s not common, but some women may have been given the 9-valent human papillomavirus (HPV) vaccine either during or before pregnancy. A study examines the effect of such exposure on adverse birth outcomes.

Tackling vaccine hesitancy for the coronavirus disease 2019 (COVID-19) is going to be an important component of achieving the herd immunity needed to end the pandemic.

Pfizer/BioNTech has released data on their coronavirus disease 2019 (COVID-19) vaccine that indicates that its highly effective in children aged 12 to 15 years.

Moderna announces beginning of coronavirus disease 2019 (COVID-19) vaccine trial that include children aged 6 months to >12 years.

A safe coronavirus 2019 disease (COVID-19) vaccine that can be administered to most of the pediatric population is a necessity for ending the pandemic, but trials for younger children have not occurred. The president of the American Academy of Pediatrics (AAP) wrote to key COVID-19 officials about the need to change this.

As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?

Vaccine hesitancy is nothing new in pediatrics. However, the increased hesitancy for the COVID-19 vaccine could prove problematic.